Loading...
MCK
XNYS
Market cap123bUSD
Nov 20, Last price  
1,069.43USD
1D
0.68%
1Q
24.51%
Jan 2017
661.43%
Name

Mckesson Corp

Chart & performance

D1W1MN
XNYS:MCK chart
P/E
25.93
P/S
0.31
EPS
41.24
Vol. 1Y
31.12%
Shs. 5Y
-5.03%
Rev. 5Y
11.11%
Div Yld LY
0.29%
Div Yld TTM
0.32%
Revenues
403.43b
+12.36%
92,977,000,000101,703,000,000106,632,000,000108,702,000,000112,084,000,000122,734,000,000122,455,000,000137,609,000,000179,045,000,000190,884,000,000198,533,000,000208,357,000,000214,319,000,000231,051,000,000238,228,000,000263,966,000,000276,711,000,000308,951,000,000359,051,000,000403,430,000,000
Net income
4.76b
+44.52%
963,000,000990,000,000823,000,0001,263,000,0001,130,000,0001,403,000,0001,338,000,0001,263,000,0001,476,000,0002,258,000,0005,183,000,00067,000,00034,000,000900,000,000-4,539,000,0001,114,000,0003,560,000,0003,002,000,0003,295,000,0004,762,000,000
CFO
6.16b
+1.15%
1,539,000,000869,000,0001,351,000,0002,316,000,0002,338,000,0002,950,000,0002,483,000,0003,136,000,0003,112,000,0003,672,000,0004,744,000,0004,345,000,0004,036,000,0004,374,000,0004,542,000,0004,434,000,0005,159,000,0004,314,000,0006,085,000,0006,155,000,000
Dividend
Dec 01, 20260.94 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.

Related entities

Subsidiaries (4)
MCKESSON MEDICAL-SURGICAL TOP HOLDINGS INC.
MCKESSON UK FINANCE II LIMITED
MCKESSON INFORMATION SOLUTIONS FINANCE S.A R.L.

Key people

Independent Chairman of the Board · since 2022
Chief Executive Officer, Director · since 2019
Chief Financial Officer, Executive Vice President · since 2018
Michele Lau
Executive Vice President, Chief Legal Officer · since 2024
Thomas Rodgers
Executive Vice President, Chief Strategy and Business Development Officer · since 2020
Leann Smith
Chief Human Resources Officer, Executive Vice President · since 2022
Independent Director · since 2018
Independent Director · since 2025
Independent Director · since 2022
Independent Director · since 2024
Independent Director · since 2025
James Hinton
Independent Director · since 2022
Bradley Lerman
Independent Director · since 2018
Independent Director · since 2019
Independent Director · since 2024
Kathleen Wilson - Thompson
Independent Director · since 2022
IPO date
Nov 10, 1994
Employees
45,000
Domiciled in
US
Incorporated in
US
Legal address
C/O CORPORATION SERVICE COMPANY
251 LITTLE FALLS DRIVE
WILMINGTON, DE 19808
US
Headquarters
6555 N. STATE HIGHWAY 161
IRVING, TX 75039
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT